BTK and aneurysmal bone cyst: The widely acknowledged feature of the ABC-DLBCL subtype is its chronic active BCR signaling, proceeding via the BTK/CARD11 pathway; hence, the deletion of BTK is deleterious for ABC-DLBCL cells [61].